Search research articles
Contact Us
Filters
Showing results (231-240 of 245) with videos related to
Page
of 25
Sort By:
Blood
|
April 5, 2017
Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL
Paul M Barr, Jennifer R Brown, Peter Hillmen, et al.
Blood
|
March 8, 2019
Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab
John C Byrd, Peter Hillmen, Susan O'Brien, et al.
Internal Medicine Journal
|
September 24, 2023
Chronic lymphocytic leukaemia Australasian consensus practice statement
Mary A Anderson, Rory Bennett, Xavier Badoux, et al.
British Journal of Haematology
|
August 31, 2006
Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray
Larissa Belov, Stephen P Mulligan, Nicole Barber, et al.
Nature Cell Biology
|
September 8, 2022
Comparative roadmaps of reprogramming and oncogenic transformation identify Bcl11b and Atoh8 as broad regulators of cellular plasticity
A Huyghe, G Furlan, J Schroeder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2018
Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial
Stephan Stilgenbauer, Barbara Eichhorst, Johannes Schetelig, et al.
The Medical Journal of Australia
|
May 14, 2020
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance
Robert Weinkove, Zoe K McQuilten, Jonathan Adler, et al.
Mycoses
|
September 15, 2019
Ibrutinib-associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: An observational study
Rosa Ruchlemer, Ronen Ben-Ami, Maskit Bar-Meir, et al.
Journal of the American College of Cardiology
|
December 21, 2019
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)
Raza M Alvi, Matthew J Frigault, Michael G Fradley, et al.
ACS Central Science
|
August 29, 2022
An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with <i>In Vivo</i> Efficacy against Drug-Resistant Gram-Negative Infections
Erica N Parker, Brett N Cain, Behnoush Hajian, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 245) with videos related to
Sort By:
Page
of 25
Blood
|
April 5, 2017
Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL
Paul M Barr, Jennifer R Brown, Peter Hillmen, et al.
Blood
|
March 8, 2019
Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab
John C Byrd, Peter Hillmen, Susan O'Brien, et al.
Internal Medicine Journal
|
September 24, 2023
Chronic lymphocytic leukaemia Australasian consensus practice statement
Mary A Anderson, Rory Bennett, Xavier Badoux, et al.
British Journal of Haematology
|
August 31, 2006
Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray
Larissa Belov, Stephen P Mulligan, Nicole Barber, et al.
Nature Cell Biology
|
September 8, 2022
Comparative roadmaps of reprogramming and oncogenic transformation identify Bcl11b and Atoh8 as broad regulators of cellular plasticity
A Huyghe, G Furlan, J Schroeder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2018
Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial
Stephan Stilgenbauer, Barbara Eichhorst, Johannes Schetelig, et al.
The Medical Journal of Australia
|
May 14, 2020
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance
Robert Weinkove, Zoe K McQuilten, Jonathan Adler, et al.
Mycoses
|
September 15, 2019
Ibrutinib-associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: An observational study
Rosa Ruchlemer, Ronen Ben-Ami, Maskit Bar-Meir, et al.
Journal of the American College of Cardiology
|
December 21, 2019
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)
Raza M Alvi, Matthew J Frigault, Michael G Fradley, et al.
ACS Central Science
|
August 29, 2022
An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with <i>In Vivo</i> Efficacy against Drug-Resistant Gram-Negative Infections
Erica N Parker, Brett N Cain, Behnoush Hajian, et al.
Page
of 25